Status:
COMPLETED
Study to Evaluate The Analgesic Efficacy and Safety of Intravenous Paracetamol in Subjects With Postoperative Pain After Total Hip Arthroplasty
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The main purpose is to evaluate the analgesic efficacy of 1g of intravenous (Iv) paracetamol versus i.v. placebo, administered every 6h, as measured by the reduction of the 24-hour cumulative dose of ...
Eligibility Criteria
Inclusion
- Spinal anesth
- BMI 10-35
- No pain conditions/concom med may alter pain quantif.
Exclusion
- Other add. surgery
- Liver/Renal function altered
- coagulation alterations
- Respir / Cardiac insufficiency
- Agents affecting microsomal syst
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00344045
Start Date
April 1 2006
End Date
February 1 2008
Last Update
November 4 2015
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Alcorcón, Spain, 28922
2
Local Institution
Barcelona, Spain, 08024
3
Local Institution
Madrid, Spain, 28007
4
Local Institution
Madrid, Spain, 28041